Pharmaceuticals companies shares mixed at the close of trading
Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. rose $.36 or .5 percent, to $75.40.
Managed Care companies shares up at 10 a.m.
Shares of some top managed care companies are up at 10 a.m.: Aetna rose $.57 or .7 percent, to $79.34.
Medical Devices companies shares mixed at the close of trading
Shares of some top medical devices companies were mixed at the close of trading: Allergan fell $2.15 or 1.3 percent, to $163.41.
Managed Care companies shares up at the close of trading
Shares of some top managed care companies were up at the close of trading: Aetna rose $.18 or .2 percent, to $78.95.
Biotechnology companies shares up at the close of trading
Shares of some top biotechnology companies were up at the close of trading: Amgen Inc. rose $1.97 or 1.5 percent, to $134.79.
Top 10 Nasdaq-traded stocks posting largest percentage increases
A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Digital Ally Inc. rose 57.4 percent to $12.50.
Japan offers to provide anti-influenza drug for possible Ebola treatment
Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak.
Pharmaceuticals companies shares up at 10 a.m.
Shares of some top pharmaceuticals companies are up at 10 a.m.: Baxter International Inc. rose $.45 or .6 percent, to $75.49.
Medical Devices companies shares up at 10 a.m.
Shares of some top medical devices companies are up at 10 a.m.: Allergan rose $.32 or .2 percent, to $165.88.
Switzerland's Roche to buy InterMune, US-based developer of lung disease drugs, in $8.3B deal
Swiss pharmaceutical company Roche says it will buy a California-based developer of treatments for lung diseases, InterMune Inc., in a deal worth $8.3 billion.
Allergan reviewing special meeting requests as Valeant ratchets up $53B hostile takeover bid
Botox maker Allergan says it's reviewing shareholder requests for a special meeting to consider replacing most of its board.
Biotechnology companies shares mixed at the close of trading
Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. rose $.29 or .2 percent, to $132.82.
Managed Care companies shares mixed at the close of trading
Shares of some top managed care companies were mixed at the close of trading: Aetna fell $.58 or .7 percent, to $78.77.
Pharmaceuticals companies shares mixed at 1 p.m.
Shares of some top pharmaceuticals companies are mixed at 1 p.m.: Baxter International Inc. fell $.57 or .8 percent, to $75.23.
Medical Devices companies shares mixed at 1 p.m.
Shares of some top medical devices companies are mixed at 1 p.m.: Allergan rose $1.12 or .7 percent, to $165.50.
Pharmaceuticals companies shares mixed at the close of trading
Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. rose $.55 or .7 percent, to $75.80.
Biotechnology companies shares up at 1 p.m.
Shares of some top biotechnology companies are up at 1 p.m.: Amgen Inc. rose $.73 or .6 percent, to $133.26.
Managed Care companies shares mixed at 1 p.m.
Shares of some top managed care companies are mixed at 1 p.m.: Aetna fell $.14 or .2 percent, to $79.21.
Medical Devices companies shares mixed at the close of trading
Shares of some top medical devices companies were mixed at the close of trading: Allergan rose $1.25 or .8 percent, to $164.38.
Lilly says psoriasis treatment outperforms placebo, competitor drug in late-stage research
Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.